相关实验视频

Updated: May 10, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

通过主动点击加载制备的脂质体内多塞-谷氨酸的治疗指数得到改善

XueLi Jin¹, Qing Zhou², Lei Cao³

¹Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

|August 5, 2024

概括

一种新型的多塞 (DTX) 与谷氨 (GSH) 结合的脂质体配方显著增强抗瘤活性,同时降低中性质衰竭和神经毒性等严重毒性,为当前的DTX注射提供了一个有前途的替代方案.

科学领域:

纳米医学是一种纳米医学.
药物输送系统药物输送系统
在瘤学瘤学.

背景情况:

多塞 (DTX) 的临床使用受到严重剂量限制性毒性,包括与其当前的聚酸盐80配方相关的中性质减退和外围神经毒性等的限制.
缺少DTX的现有替代配方,需要开发更安全,更有效的输送系统.

研究的目的:

开发和评估一种与谷氨 (GSH) 结合的多塞 (DTX) 的新型脂质体配方.
在临床前模型中评估脂质体DTX-GSH配方与传统DTX注射相比的疗效和安全性.

主要方法:

多塞 (DTX) 被封装在脂质体中,作为一种使用点击化学药物加载方法的水性谷氨 (GSH) 结合前药物.
封装效率,药物加载能力和体外药物释放动力学是特征.
抗瘤疗效和毒性 (中性缺陷症,外围神经毒性) 在4T1乳腺瘤携带的小鼠 (皮下和正管模型) 中进行了评估.

主要成果:

脂质体DTX-GSH配方实现了高封装效率 (∼95%) 和负载能力 (∼30%).
观察到持续的DTX释放 (48小时内≤50%),导致针对大型瘤 (>500毫米3) 的抗瘤活性显著改善.
脂质体DTX-GSH显示显著降低中性质衰竭和外围神经毒性,与同等剂量的聚酸盐80溶解DTX相比.

结论:

开发的脂质体DTX-GSH配方为商业中注射的多塞塔克塞尔提供了更优质的替代方案.
这种新的配方有效地提高了抗瘤疗效,同时显著减轻了剂量限制性毒性,为改善癌症治疗铺平了道路.

关键词:

抗瘤疗效抗瘤疗效点击药物装载点击药物装载.多塞塔克塞尔 (Docetaxel) 是一种药物释放释放药物释放药物释放药物脂质体是一种脂质体.有毒性有毒性

更多相关视频

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.